Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] Molecular bioanalysis considerations along the drug development journey 11 days 10 hours 36 mins 33 secs REGISTER NOW!

Video: Antibody drug–conjugates characterization (Waters Corporation)

21 May 2015
Chromatography MS (LC–MS/MS, HRMS, IMS)

This video discusses powerful analytical tools which can be used to interrogate and understand ADCs. In particular, it outlines:

  • Characterizing ADCs with hydrophobic interaction chromatography
  • Deriving DAR via native UPLC/MS
  • Resolving positional isomers by 2D UPLC/MS
  • Identifying conjugation by peptide mapping

Top content

  • Waters launches the Xevo TQ Absolute XR at ASMS 2025
  • How can diagnostic laboratories accelerate the clinical adoption of allogeneic cell therapies?
  • Why NGS ELN deployments fail

Related tags

ADC LC-MS MS
Previous article Next article

Related articles

4 MAY 2018 GENERAL INTEREST

Applying LC-MS/MS techniques to the development of biologics

16 APR 2014 CHROMATOGRAPHY

Application note: TripleTOF® 5600+ System (AB SCIEX)

11 OCT 2012 COLLABORATIONS AND MERGERS

2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines

21 AUG 2011 CHROMATOGRAPHY

Development of methods to monitor ionization modification from dosing vehicles and phospholipids in study samples

11 AUG 2016 JOURNAL ARTICLES

High throughput analysis at microscale: performance of ionKey/MS with Xevo G2-XS QTof under rapid gradient conditions (Waters Corporation)

27 DEC 2017 BIOMARKERS

2D-LC–MS/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone